(MDGL) Madrigal - Performance 55.6% in 12m
Compare MDGL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
70.56%
#6 in Group
Rel. Strength
90.91%
#726 in Universe
Total Return 12m
55.61%
#27 in Group
Total Return 5y
274.51%
#7 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -7.81%
(?) Percentile in Group
12m Total Return: MDGL (55.6%) vs XBI (-5.4%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
-4.25% | 15.2% | 163% | 12.1 | 10.6 | 1.43 | 81.5% | 18.5% |
HLN NYSE Haleon |
2.64% | 25.8% | 43.6% | 24.4 | 20.2 | 1.79 | 64.4% | 6.58% |
AMGN NASDAQ Amgen |
-7.54% | 5.43% | 43.3% | 38.5 | 13.8 | 0.97 | -42.0% | -25.9% |
LONN SW Lonza |
8.68% | 15.4% | 38.7% | 65.8 | 33.6 | 1.23 | 12.6% | -10.3% |
BIM PA Biomerieux |
2.77% | 21.2% | 8.84% | 31 | 24.2 | 1.45 | -58.7% | -25.1% |
KMDA NASDAQ Kamada |
-1.94% | 25.9% | -9.16% | 26.6 | 24 | 0.96 | 80.4% | 43% |
ERF PA Eurofins Scientific SE |
15.4% | 0.42% | 17.2% | 26.6 | 13.6 | 0.56 | -67.4% | -17.7% |
BMRN NASDAQ Biomarin Pharmaceutical |
-7.7% | -24.7% | -30.6% | 28.6 | 15.9 | 0.43 | 67.5% | 59.7% |
Performance Comparison: MDGL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for MDGL
Total Return (including Dividends) | MDGL | XBI | S&P 500 |
---|---|---|---|
1 Month | 1.15% | 5.55% | -0.45% |
3 Months | 0.69% | -9.75% | -6.29% |
12 Months | 55.61% | -5.39% | 13.04% |
5 Years | 274.51% | -13.20% | 111.82% |
Trend Score (consistency of price movement) | MDGL | XBI | S&P 500 |
1 Month | 23.8% | 70% | 47.5% |
3 Months | -44.4% | -88.1% | -87.3% |
12 Months | 71.2% | -44.4% | 54.3% |
5 Years | 66.4% | -53.6% | 84.2% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #125 | -4.17% | 1.60% |
3 Month | #54 | 11.6% | 7.45% |
12 Month | #28 | 64.5% | 37.7% |
5 Years | #6 | 331% | 76.8% |
FAQs
Does MDGL Madrigal outperforms the market?
Yes,
over the last 12 months MDGL made 55.61%, while its related Sector, the SPDR S&P Biotech (XBI) made -5.39%.
Over the last 3 months MDGL made 0.69%, while XBI made -9.75%.
Over the last 3 months MDGL made 0.69%, while XBI made -9.75%.
Performance Comparison MDGL vs Indeces and Sectors
MDGL vs. Indices MDGL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | 0.28% | 1.60% | 4.12% | 42.6% |
US NASDAQ 100 | QQQ | -0.64% | -0.75% | 3.41% | 40.6% |
US Dow Jones Industrial 30 | DIA | 0.82% | 4.0% | 4.88% | 46.3% |
German DAX 40 | DAX | 0.64% | 1.37% | -14.0% | 30.6% |
Shanghai Shenzhen CSI 300 | CSI 300 | 3.93% | 4.36% | 7.82% | 50.6% |
Hongkong Hang Seng | HSI | 0.68% | 2.67% | 3.59% | 42.7% |
India NIFTY 50 | INDA | 2.80% | -3.73% | 4.24% | 52.7% |
Brasil Bovespa | EWZ | 1.91% | -1.68% | -1.58% | 62.4% |
MDGL vs. Sectors MDGL is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | 0.13% | 1.75% | -1.86% | 32.2% |
Consumer Discretionary | XLY | 0.25% | 1.74% | 2.95% | 40.9% |
Consumer Staples | XLP | 2.34% | 1.97% | 0.02% | 44.7% |
Energy | XLE | 4.54% | 15.2% | 9.26% | 64.9% |
Financial | XLF | 1.39% | 3.16% | -2.81% | 32.9% |
Health Care | XLV | 2.98% | 5.82% | 9.28% | 56.8% |
Industrial | XLI | -0.04% | 0.85% | 3.08% | 44.9% |
Materials | XLB | 2.09% | 4.37% | 12.0% | 60.1% |
Real Estate | XLRE | 0.39% | 2.25% | 3.96% | 37.3% |
Technology | XLK | -1.28% | -1.28% | 7.07% | 45.2% |
Utilities | XLU | 1.56% | 1.05% | -0.30% | 34.8% |
Aerospace & Defense | XAR | -0.75% | -5.83% | -9.76% | 28.1% |
Biotech | XBI | 0.44% | -4.40% | 19.4% | 61.0% |
Homebuilder | XHB | 1.55% | 3.23% | 19.1% | 61.8% |
Retail | XRT | 1.52% | 2.31% | 10.1% | 57.1% |